Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark

Journal of Hospital Infection

Volumn 33, Issue 4, 1996, Pages 289-300

  Zimakoff, J ^a,g   Pedersen, F Bangsgaard ^e   Bergen, L ^d   Baago Nielsen J ^c   Daldorph, B ^e   Espersen, F ^b   Gahrn Hansen, B ^e   Hoiby N ^f   Jepsen, O B ^a   Joffe, P ^c   Kolmos, H J ^d   Klausen, M ^e   Kristoffersen, K ^d   Ladefoged, J ^f   Olesen Larsen, S ^a   Rosdahl, V T ^b   Scheibel, J ^c   Storm, B ^c,f   Tofte Jensen, P ^h   Lokkegaard H ^h   Nielsen, B ^h   Wurr, M ^h   Wang, P ^h   Antonsen, S ^h   Eriksen, N R ^h   Ladefoged, S D ^h   more..

^a STATENS SERUM INSTITUT   (Denmark)

^b Staphylococcus Laboratory   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f University of Copenhagen   (Denmark)

^g National Center for Hospital Hygiene Copenhagen   (Denmark)

^h NONE

Author keywords

CAPD; Carriage; Elimination; Haemodialysis; Infections; Phage type; Staphylococcus aureus

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIOPHAGE TYPING; BACTERIUM CARRIER; BACTERIUM CULTURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST EFFECTIVENESS ANALYSIS; DENMARK; DIABETES MELLITUS; FEMALE; HEALTH CARE POLICY; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; PERITONEAL DIALYSIS; PERITONITIS; RISK ASSESSMENT; SEPTICEMIA; SKIN; STAPHYLOCOCCUS AUREUS; VEIN CATHETERIZATION; WOUND INFECTION;

EID: 16044373901     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(96)90015-8     Document Type: Article

References (25)

1. Piraino B. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients. Am J Kidney Dis 1990; 2: 89-95.
2. Holmes CJ. Catheter-related biofilm. In: Coles GA, Davies M, Williams JD, Eds. CAPD: Host Defense Nutrition and Ultrafiltration. Contributions to Nephrology. Basel 1990: vol. 85: 49-56.
3. Ralston AJ, Harlow GR, Jones DM, Davis P. Infections of Scribner and Brescia arteriovenous shunts. Br Med J 1991; 3: 408-409.
4. Dobkin JF, Miller MH, Steigbigel NH. Septicemia in patients with chronic hemodialysis. Ann Intern Med 1978; 88: 28-33.
5. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. A prospective study of infections in haemodialysis patients: patient hygiene and other risk factors for infection. J Clin Microbiol 1988; 7: 1257-1262.
6. Chow J, Yee V. Staphylococcus aureus nasal carriage in hemodialysis patients. Arch Intern Med 1989; 149: 1258-1262.
7. Goldblum SE, Ulrich JZ, Goldman RS, Reed WP. Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of Staphylococcal carriage. Am J Kidney Dis 1982; 2: 281-286.
8. Goldblum SE, Reed WP, Ulrich JZ, et al. Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 1978; 7: 1140-1163.
9. Rebel MH, Van Furth R, Stevens P, et al. The flora of renal hemodialysis shunt sites. J Clin Pathol 1975; 28: 29-32.
10. Kirmani N, Tuazon CU, Murray HW, et al. Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978; 138: 1657-1659.
11. Sewell C, Clarridge J, Lacke C, et al. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 1982; 248: 1493-1495.
12. Davies SJ, Ogg CS, Cameron JS, et al. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with CAPD. Perit Dial Intern 1989; 9: 61-64.
13. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 8: 505-509.
14. Parker MT. The significance of phage-typing patterns in S. aureus. In: Esmond CSF, Adlam C, Eds. Staphylococci and Staphylococcal Infections. Vol. I. London: Academic Press; 1983: 33-62.
15. Sesso S, Draibe S, Castelo A, Sato I, Lerne I, Barbosa D, Ramos O. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1989; 5: 264-268.
16. Ludlam HA, Young AE, Berry AJ, Phillips I. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis. J Hosp Infect 1989; 14: 293-301.
17. Zimakoff J, Rosdahl VT, Petersen W, Scheibel J. Recurrent Staphylococcal furunculosis in families. Scand J Infect Dis 1988; 20: 403-405.
18. Casewell MW, Hill RLR. In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus. J Antimicrobiol Chemother 1985; 15: 523-531.
19. Casewell MW, Hill RLR. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid') - a controlled trial. J Antimicrobiol Chemother 1986; 17: 365-372.
20. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, Wenzel RP. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114: 101-106.
21. Doebbeling BN, Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994; 154: 1505-1508.
22. Boelaert JR, Van Landuyt HW, Godard CA, Daneels RF, Schurgers MI, Matthys EG. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemia in haemodialysis patients. Nephrol Dial Transplant 1993; 8: 235-239.
23. Kauffman CA, Terpenning MS, He X, Zarins LT, Ramsey MA, Jorgensen KA, Sottile WS, Bradley SF. Attempts to eradicate methieillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin ointment. Am J Med 1993; 94: 371-378.
24. Scully BE, Brions F, Gu JW, Neu HC. Mupirocin treatment of nasal staphylococcal colonization. Arch Intern Med 1992; 152: 353-356.
25. Connolly S, Noble WC, Philips I. Mupirocin resistance in coagulase-negative staphylococci. J Med Microbiol 1993; 39: 450-453.